Concepedia

Philipp Hadwiger

PH

32

Publications

4.1K

Citations

25

H-Index

1999

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Ludwig-Maximilians-Universität München

Center for NanoScience

The University of Texas Southwestern Medical Center

University of California San Diego

Philipp Hadwiger is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, molecular biology, and natural sciences.

Top concepts

Publications per year

1999–2019

32

Publications

32

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Maria Frank-Kamenetsky, Aldo Grefhorst, Norma N. Anderson et al. · Proceedings of the National Academy of Sciences · 2008 · 635 citations · Full text

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma

Maria-del-Mar Inda, Rudy Bonavia, Akitake Mukasa et al. · Genes & Development · 2010 · 537 citations · Full text

, , +16

Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells

Christina Lorenz, Philipp Hadwiger, Matthias John et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 333 citations

, , +9

Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection

Christine I. Wooddell, David B. Rozema, Matthias John et al. · Molecular Therapy · 2013 · 289 citations · Full text

Solid‐Phase Synthesis of Sequence‐Defined T‐, i‐, and U‐Shape Polymers for pDNA and siRNA Delivery

David Schaffert, Christina Troiber, Eveline E. Salcher et al. · Angewandte Chemie International Edition · 2011 · 192 citations

Rows per page

1–5 of 32